BSE filing, NSE: EMAMIPAP. Summary written from the filing by ALFA Finder's alert engine.
Emami Paper Mills Ltd: key numbers
- Share price
- ₹115.01
- Market cap
- ₹695.8 Cr
- Revenue (annual)
- ₹1,907 Cr
- Net profit (annual)
- ₹61.38 Cr
- P/E (TTM)
- 7.4×Sector 43.1×
- Promoter holding
- 74.97%+0.00% QoQ
- FII holding
- 0.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emami Paper Mills Ltd
All →Emami Paper Mills Board Meeting Date
Emami Paper Mills has scheduled a board meeting for October 30, 2026, to consider and approve its unaudited financial results for the quarter and half-year.
Emami Paper Mills Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Emami Paper Mills Capital Structure Change
Emami Paper Mills has redeemed 11,25,000 unlisted Series III Optionally Convertible Redeemable Preference Shares (OCRPS) for a total consideration of ₹78.75 Crore.
- Value
- ₹78.75 Cr
Emami Paper Mills Annual General Meeting
Emami Paper Mills Limited held its 44th Annual General Meeting on September 4, 2026, via video conferencing to transact ordinary and special business items.
Emami Paper Mills Annual General Meeting
Emami Paper Mills has issued the notice for its 44th Annual General Meeting scheduled for September 4, 2026. Key agenda items include dividend declaration and director re-appointments.
Emami Paper Mills Other Announcement
Emami Paper Mills has published its Business Responsibility & Sustainability Report (BRSR) for FY 2025-26, detailing operational disclosures and ESG-related performance metrics.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.